Metastatic pulmonary adenocarcinoma to the nasopharynx at first clinical presentation: A case report and review of literature. (July 2020)

• Record Type: Journal Article
• Authors: Iqneibi, Shahad; Nazzal, Jamil; Amoudi, Runa; Owda, Basma; Al-Ibraheem, Akram; Yaser, Sameer; Al-Hussaini, Maysa
• Is Part Of: SAGE open medical case reports. Volume 8(2020)
• Publication Date: 2020-07
• Subjects: Nasopharyngeal carcinoma -- metastatic carcinoma -- lung adenocarcinoma -- FDG-PET/CT scan -- immunotherapy; Clinical medicine -- Case studies -- Periodicals; 616.09
• DOI: 10.1177/2050313X20939826
• Languages: English
• ISSNs: 2050-313X

Abstract

Metastatic carcinomas in the nasopharynx are a rarity. We report a case of a 54-year-old male patient who presented with a history of recurrent epistaxis. On evaluation, a mass in the right Rosenmüller fossa was detected, which was biopsied and diagnosed as a poorly differentiated adenocarcinoma, immunoreactive for thyroid transcription factor-1, consistent with metastatic pulmonary adenocarcinoma. Fluorodeoxyglucose–positron emission tomography/computed tomography (FDG-PET/CT) scan confirmed the presence of a mass in the upper lobe of the left lung, proven pathologically to be a poorly differentiated pulmonary adenocarcinoma, with an immunoprofile similar to the nasopharyngeal tumor. The patient underwent palliative chemotherapy, and was then shifted to immunotherapy. He is currently alive and disease free 50 months after the initial diagnosis was made. The unusual presentation of a metastatic carcinoma in the nasopharynx will be discussed, along with a review of literature. The role of immunotherapy in cancer control and greater longevity will also be presented.